Related references
Note: Only part of the references are listed.The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
A pharmacological assessment of agonists and modulators at α4β2γ2 and α4β2δ GABAA receptors: The challenge in comparing apples with oranges
Philip K. Ahring et al.
PHARMACOLOGICAL RESEARCH (2016)
Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease
Valentina Echeverria et al.
PROGRESS IN NEUROBIOLOGY (2016)
Experimental design and analysis and their reporting: new guidance for publication in BJP
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
John C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Structural and Functional Studies of the Modulator NS9283 Reveal Agonist-like Mechanism of Action at α4β2 Nicotinic Acetylcholine Receptors
Jeppe A. Olsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Physostigmine and Galanthamine Bind in the Presence of Agonist at the Canonical and Noncanonical Subunit Interfaces of a Nicotinic Acetylcholine Receptor
Ayman K. Hamouda et al.
JOURNAL OF NEUROSCIENCE (2013)
Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of α2- and α4-containing nicotinic acetylcholine receptors
D. B. Timmermann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pharmacokinetic and Pharmacodynamic Properties of Cholinesterase Inhibitors Donepezil, Tacrine, and Galantamine in Aged and Young Lister Hooded Rats
Catherine W. Goh et al.
DRUG METABOLISM AND DISPOSITION (2011)
Additional Acetylcholine (ACh) Binding Site at α4/α4 Interface of (α4β2)2α4 Nicotinic Receptor Influences Agonist Sensitivity
Simone Mazzaferro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Unraveling the High- and Low-Sensitivity Agonist Responses of Nicotinic Acetylcholine Receptors
Kasper Harpsoe et al.
JOURNAL OF NEUROSCIENCE (2011)
Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine
Yukio Ago et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Localization by site-directed mutagenesis of a galantamine binding site on α7 nicotinic acetylcholine receptor extracellular domain
Juergen Ludwig et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2010)
Old and New Pharmacology: Positive Allosteric Modulation of the α7 Nicotinic Acetylcholine Receptor by the 5-Hydroxytryptamine2B/C Receptor Antagonist SB-206553 (3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b′]di pyrrole-1(2H)-carboxamide)
John Dunlop et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a Unique Subtype-Selective GABAA Receptor Positive Allosteric Modulator: In Vitro Actions, Pharmacokinetic Properties and in Vivo Anxiolytic Efficacy
N. R. Mirza et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Epik:: a software program for pK a prediction and protonation state generation for drug-like molecules
John C. Shelley et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo
Daniel B. Timmermann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Galanthamine and non-competitive inhibitor binding to ACh-binding protein:: Evidence for a binding site on non-α-subunit interfaces of heteromeric neuronal nicotinic receptors
Scott B. Hansen et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Mapping convulsants' binding to the GABA-A receptor chloride ionophore: A proposed model for channel binding sites
A. V. Kalueff
NEUROCHEMISTRY INTERNATIONAL (2007)
Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors
S Roman et al.
BRAIN RESEARCH (2005)
RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells
SJ Lansdell et al.
MOLECULAR PHARMACOLOGY (2005)
Effect of galantamine on the human α7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity
L Texidó et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site
G Akk et al.
JOURNAL OF NEUROSCIENCE (2005)
Picrotoxin-mediated antagonism of α3β4 and α7 acetylcholine receptors
BE Erkkila et al.
NEUROREPORT (2004)
The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons:: Ca2+ signals and neurotransmitter release.
FA Dajas-Bailador et al.
MOLECULAR PHARMACOLOGY (2003)
Synthesis and evaluation of tritium labelled 10-methylgalanthamine iodide:: a novel compound to examine the mechanism of interaction of galanthamine derivatives with the nicotinic acetylcholine receptors
A Schildan et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2003)
Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors
M Samochocki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
ME Nelson et al.
MOLECULAR PHARMACOLOGY (2003)
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease
G Wilcock et al.
DRUGS & AGING (2003)
Comparative pharmacology of rat and human α7 nAChR conducted with net charge analysis
RL Papke et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
The C-elegans ric-3 gene is required for maturation of nicotinic acetylcholine receptors
S Halevi et al.
EMBO JOURNAL (2002)
Galantamine is an allosterically potentiating ligand of the human alpha 4/beta 2 nAChR
M Samochocki et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
Share Paper
